HuagongsheHuagongshe Chemistry Print Report · For research reference only
6-Bromo-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline → 6-(1-trityl-1H-pyrazol-4-yl)-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 6-Bromo-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline | HCID 22031728 | — |
| Reactant | (1-Trityl-1H-pyrazol-4-yl)boronic acid | HCID 22031737 | — |
| Product | 6-(1-trityl-1H-pyrazol-4-yl)-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline | HCID 22031520 | 94.6% |
Reaction Steps
150 mg 6-bromo-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline (compound in Production Example 456) and 134 mg 1-trityl-1H-4-pyrazolylboronic acid were reacted in the same manner as in Example 9, to give 205 mg 6-(1-trityl-1H-pyrazol-4-yl)-4-[4-(4-trifluoromethylsulfonylphenoxy)piperidin-1-yl] quinoline. This product was reacted in the same manner as in Example 67, to give 90 mg of the title compound as pale yellow crystals.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07074801B1 |
| Source dataset | uspto-grants-2006_07 |
| ORD ID | ord-56e412bd410441dda3c53c6e36267bd4 |
| Source note | uspto-grants-2006_07 |